Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Fabienne Chatreaux is active.

Publication


Featured researches published by Fabienne Chatreaux.


Tetrahedron Letters | 2000

Tosylates in palladium-catalysed coupling reactions. Application to the synthesis of arylcoumarin inhibitors of gyrase B

Laurent Schio; Fabienne Chatreaux; Michel Klich

Abstract The palladium-catalysed coupling reaction between tosylate derivatives and organostannanes has been investigated as a methodology for carbon–carbon bond formation. Aryl substituents have been successfully incorporated even in highly functionalised coumarin structures to afford new analogues of the antibiotic novobiocin.


Journal of Medicinal Chemistry | 2012

Discovery and optimization of new benzimidazole- and benzoxazole-pyrimidone selective PI3Kβ inhibitors for the treatment of phosphatase and TENsin homologue (PTEN)-deficient cancers.

Victor Certal; Frank Halley; Angela Virone-Oddos; Cécile Delorme; Andreas Karlsson; Alexey Rak; Fabienne Thompson; Bruno Filoche-Romme; Youssef El-Ahmad; Jean Christophe Carry; Pierre Yves Abecassis; Pascale Lejeune; Loic Vincent; Hélène Bonnevaux; Jean Paul Nicolas; Thomas Bertrand; Jean Pierre Marquette; Nadine Michot; Tsiala Benard; Peter Below; Isabelle Vade; Fabienne Chatreaux; Gilles Lebourg; Fabienne Pilorge; Odile Angouillant-Boniface; Audrey Louboutin; Christoph Lengauer; Laurent Schio

Most of the phosphoinositide-3 kinase (PI3K) kinase inhibitors currently in clinical trials for cancer treatment exhibit pan PI3K isoform profiles. Single PI3K isoforms differentially control tumorigenesis, and PI3Kβ has emerged as the isoform involved in the tumorigenicity of PTEN-deficient tumors. Herein we describe the discovery and optimization of a new series of benzimidazole- and benzoxazole-pyrimidones as small molecular mass PI3Kβ-selective inhibitors. Starting with compound 5 obtained from a one-pot reaction via a novel intermediate 1, medicinal chemistry optimization led to the discovery of compound 8, which showed a significant activity and selectivity for PI3Kβ and adequate in vitro pharmacokinetic properties. The X-ray costructure of compound 8 in PI3Kδ showed key interactions and structural features supporting the observed PI3Kβ isoform selectivity. Compound 8 achieved sustained target modulation and tumor growth delay at well tolerated doses when administered orally to SCID mice implanted with PTEN-deficient human tumor xenografts.


Bioorganic & Medicinal Chemistry Letters | 2001

Fine Tuning of Physico-Chemical Parameters to Optimise a New Series of Novobiocin Analogues

Laurent Schio; Fabienne Chatreaux; Véronique Loyau; Michel Murer; Anne Ferreira; Pascale Mauvais; Alain Bonnefoy; Michel Klich

A novel series of novobiocin analogues has been synthesised by removing the lipophilic aryl chain in novobiocin and introducing an amino substituent. The structural modifications have been dictated by the control of lipophilicity and the dissociation constant of the resulting compounds. Antibacterial activity of the new coumarin derivatives could be correlated with the amount of uncharged form in physiological conditions.


Bioorganic & Medicinal Chemistry Letters | 2000

Improved antibacterial activities of coumarin antibiotics bearing 5′,5′-dialkylnoviose: biological activity of RU79115

Branislav Musicki; Anne-Marie Periers; Patrick Laurin; Didier Ferroud; Yannick Benedetti; Sylvette Lachaud; Fabienne Chatreaux; Jean-Luc Haesslein; Alain Iltis; Christine Pierre; Jean Khider; Nicole Tessot; Marlene Airault; Jacques Demassey; Claudine Dupuis-Hamelin; Patrice Lassaigne; Alain Bonnefoy; Pascale Vicat; Michel Klich


Archive | 2001

Novel 1,2,3,4-tetrahydrosioquinoline, their preparation method and their use as fungicides

Didier Babin; Yannick Benedetti; Fabienne Chatreaux; John Weston


Archive | 2013

Novel thienopyrimidine derivatives, processes for the preparation thereof and therapeutic uses thereof

Jean-Christophe Carry; Fabienne Chatreaux; Stephanie Deprets; Olivier Duclos; Vincent Leroy; Sergio Mallart; Dominique Melon-Manguer; Maria Mendez-Perez; Fabrice Vergne


Archive | 2003

Novel 1,2,3,4-tetrahydroisoquinoline, their preparation method and their use as fungicides

Didier Babin; Yannick Benedetti; Fabienne Chatreaux; John Weston


Archive | 2013

Thienopyrimidine derivatives, processes for the preparation thereof and therapeutic uses thereof

Jean-Christophe Carry; Fabienne Chatreaux; Stephanie Deprets; Olivier Duclos; Vincent Leroy; Sergio Mallart; Dominique Melon-Manguer; Maria Mendez-Perez; Fabrice Vergne


Archive | 2017

Therapeutic uses of novel thienopyrimidine derivatives

Jean-Christophe Carry; Fabienne Chatreaux; Stephanie Deprets; Olivier Duclos; Vincent Leroy; Sergio Mallart; Maria Mendez-Perez; Fabrice Vergne


Archive | 2012

New derivatives of thienopyrimidines, their preparation processes and their therapeutic uses

Jean-Christophe Carry; Fabienne Chatreaux; Stephanie Deprets; Olivier Duclos; Vincent Leroy; Sergio Mallart; Dominique Melon-Manguer; Maria Mendez-Perez; Fabrice Vergne

Collaboration


Dive into the Fabienne Chatreaux's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Laurent Schio

Centre national de la recherche scientifique

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge